Clonidine
Benzenamine,2,6-dichloro-N-2-imidazolidinylidene-. 2-[(2,6-Dichlorophenyl)imino]imidazolidine [4205-90-7]. »Clonidine contains not less than 99.0percent and not more than 101.0percent of C9H9N3Cl2,calculated on the dried basis.
Packaging and storage
Preserve in tight containers,and store at room temperature.
Identification
A:
Infrared Absorption á197Kñ.
B:
Ultraviolet Absorption á197Uñ
Solution:
0.3mg per mL.
Medium:
0.01Nhydrochloric acid.
Absorptivities for the maxima at 271and 279should be about 2.1and 1.8,calculated on the dried basis.
Appearance of solution
Color of solution
Dissolve 1.0g in 10.0mLof methanol:the color of the solution is not more intense than 10mLof a Standard solution containing 4.8µg per mLof potassium chromate in water,when compared in matched color-comparison tubes (see Visual Comparisonunder Spectrophotometry and Light-Scattering á851ñ).
Turbidity
The test solution prepared as directed under Color of solutionhas no more turbidity than 10mLof methanol,when compared in matched color-comparison tubes (see Visual Comparisonunder Spectrophotometry and Light-Scattering á851ñ).
Loss on drying á731ñ
Dry it under vacuum at 60to constant weight:it loses not more than 0.5%of its weight.
Residue on ignition á281ñ
Ignite at 500±25to constant weight:not more than 0.1%.
Heavy metals,Method IIá231ñ:
10µg per g.
Chromatographic purity
Solution A
Dissolve 4g of monobasic potassium phosphate in 1000mLwater.Adjust with 1Mphosphoric acid,prepared by diluting 115g of phosphoric acid and diluting with water to 1000mL,to a pHof 4.0.
Solution B
Combine 750mLof acetonitrile with 250mLof Solution A.
Blank
Solution A.
Mobile phase
Use variable mixtures of Solution Aand Solution Bas directed for Chromatographic system(see System Suitabilityunder Chromatography á621ñ).
Acetylclonidine solution
Dissolve about 1mg of USP Clonidine Related Compound A RSin 1mLof acetonitrile,and dilute with Solution Ato 20mL.
System suitability solution
Combine an accurately weighed quantity of USP Clonidine RSand an appropriate volume ofAcetylclonidine solution,and dissolve in and dilute with Solution Ato obtain a solution containing about 0.86mg per mLand 0.86µg per mL,respectively.
Standard solution
Dissolve an accurately weighed quantity of USP Clonidine RSin Solution A,and dilute quantitatively,and stepwise if necessary,with Solution Ato obtain a solution having a known concentration of about 8.6µg per mL.
Test solution
Transfer about 43mg of Clonidine,accurately weighed,to a 50-mLvolumetric flask,dissolve in and dilute with Solution Ato volume,and mix.
Chromatographic system (see Chromatography á621ñ)
The liquid chromatograph is equipped with 210-nm detector and a 3.0-mm ×15-cm column that contains 5-µm packing L56.The column temperature is maintained at 40.The flow rate is about 1.5mLper minute.The chromatograph is programmed as follows.
Procedure
Separately inject equal volumes (about 5µL)of the Standard solutionand the Test solutioninto the chromatograph,record the chromatograms,and measure the peak responses for all peaks not observed in the Blank.Calculate the percentage of each impurity in the Clonidine taken by the formula:
5(C/W)(ri/rS),
in which Cis the concentration,in µg per mL,of USP Clonidine RSin the Standard solution;Wis the weight,in mg,of Clonidine used to prepare the Test solution;riis the peak response for each impurity in the Test solution;and rSis the peak response of clonidine in the Standard solution:not more than 0.1%of any individual impurity is found;and not more than 0.2%of total impurities is found.
Organic volatile impurities,Method IVá467ñ
:meets the requirements.
Assay
Dissolve about 190mg of Clonidine,accurately weighed,in about 100mLof glacial acetic acid.Titrate with 0.1Nperchloric acid VS,determining the endpoint potentiometrically,using a silversilver chloride glass combination electrode with liquid junction (see Titrimetry á541ñ).Perform a blank determination,and make any necessary correction (see Titrimetry á541ñ).Each mLof 0.1Nperchloric acid is equivalent to 23.01mg of C9H9N3Cl2.
Auxiliary Information
Staff Liaison:Andrzej Wilk,Ph.D.,Senior Scientific Associate
Expert Committee:(PA5)Pharmaceutical Analysis 5
USP28NF23Page 512
Pharmacopeial Forum:Volume No.29(1)Page 58
Phone Number:1-301-816-8305
|